Victory Capital Management Inc Ironwood Pharmaceuticals Inc Transaction History
Victory Capital Management Inc
- $95.7 Billion
- Q4 2024
A detailed history of Victory Capital Management Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 213,292 shares of IRWD stock, worth $345,533. This represents 0.0% of its overall portfolio holdings.
Number of Shares
213,292
Previous 218,009
2.16%
Holding current value
$345,533
Previous $896,000
5.36%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding IRWD
# of Institutions
243Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$37.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$31.7 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$26.6 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$19 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$15.3 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $248M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...